CRISP-Disp Leverages CRISPR-Cas9 to Deliver RNA Structures to Targets in the Genome
News Jun 10, 2015
The method enables the researchers to deliver artificial RNA devices — such as RNA processors, scaffolds, and imaging applications — to specific points on the genome. The work was led by John Rinn who, with his colleagues, is using the approach to better study long, non-coding RNAs (lncRNAs), which are hard to study using traditional knockout methods. With CRISP-Disp, the researchers can relocate lncRNAs to study them in isolation.
To learn more, read the team’s paper, which was published online by the journal Nature Methods.
RELATED ARTICLES
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease Risk
NewsScientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.
READ MORE
New Subtype of Prostate Cancer
NewsResearchers led by the University of Michigan Rogel Cancer Center have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease.
READ MORE
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone Tumors
NewsThe first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.
READ MOREComments | 0 ADD COMMENT
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Login
You must be logged in to post a comment.